Visiting CPHI Barcelona?
Schedule a Meet

Alectinib M4 metabolite D4

Product Information

Product Alectinib M4 metabolite D4
CAT No. CS-O-32642
CAS No. 1256585-04-2 (Unlabeled)
Status price
Category Stable Isotopes
Mol. Wt. 460.6 g/mol mol/g
Mol. For. C28H28D4N4O2
Hazardous This is not a Hazardous Compound

Product Description

Alectinib M4 metabolite D4 is a chemical compound that is produced as a metabolite of Alectinib, a medication used for the treatment of advanced non-small cell lung cancer. Alectinib M4 metabolite D4 is an active metabolite of Alectinib and has similar pharmacological effects. Alectinib M4 metabolite D4 is a potent inhibitor of the anaplastic lymphoma kinase (ALK) and the c-ros oncogene 1 (ROS1). These proteins are known to promote the growth and spread of cancer cells in the body. By inhibiting these proteins, Alectinib M4 metabolite D4 slows down the growth and spread of cancer cells, thereby helping to manage cancer. Alectinib M4 metabolite D4 is usually administered orally, and its dosage is determined by a healthcare professional based on the patient's medical condition and response to treatment. The medication is available in capsule form, and it is important to follow the prescribed dosage and duration of treatment. Like all medications, Alectinib M4 metabolite D4 has potential side effects. Some of the common side effects include fatigue, nausea, vomiting, diarrhea, and constipation. Patients undergoing treatment with Alectinib M4 metabolite D4 should be monitored closely by a healthcare professional for any adverse effects or allergic reactions. In conclusion, Alectinib M4 metabolite D4 is an important medication used in the management of advanced non-small cell lung cancer. Its potent inhibitory effects on ALK and ROS1 make it a valuable treatment option for patients with this condition.

Additional Information

Packing Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled No
Parent API Alectinib
Therapeutic Anti-Cancer / Oncology
Canonical Smiles CCC1=CC2=C(C=C1N3CCC(CC3)NCCO)C(C4=C(C2=O)C5=C(N4)C=C(C=C5)C#N)(C)C
Inchl InChI=1S/C28H32N4O2/c1-4-18-14-21-22(15-24(18)32-10-7-19(8-11-32)30-9-12-33)28(2,3)27-25(26(21)34)20-6-5-17(16-29)13-23(20)31-27/h5-6,13-15,19,30-31,33H,4,7-12H2,1-3H3
IUPAC 9-ethyl-8-[4-(2-hydroxyethylamino)piperidin-1-yl]-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile
Hazardous No

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information Use proper personal protective equipment
Handling Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing Wear appropriate protective clothing to minimize contact with skin.
Skin Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes Wear safety glasses and chemical goggles if splashing is possible.
Inhalation Remove from exposure and move to fresh air immediately.

What we promise?

  • 30-Days Money Back
  • Complete Documentation
  • Worldwide Delivery
  • Product Accuracy

Sample Label

logo Alectinib M4 metabol... www.clearsynth.com 
 CAT : CS-O-32642 BATCH : CSC-WWW0757

 MF: C28H28D4N4O2
 CAS: 1256585-04-2 (Unlabeled)
 Date of Anaysis: 22-Aug-2023
 Retest Date: 22-Jun-2026
MW: 460.6 g/mol

Store at refrigerator (2-8C)
Qty: 60 MG 
 Only for R & D and Analytical purpose, Not for Human Consumption.

Sample Packaging

Sample Packaging

Sample Vials

Sample Vials
Product List

Related Products